First Solar (FSLR) posted stronger-than-expected Q1 results and saw shares rise amid tightening U.S. module supply and rising module prices. Recent manufacturing moves — including a new perovskite-hybrid partnership, upstream investments abroad, and industry patent positioning — sharpen the competitive picture for First Solar’s CdTe thin-film advantage.

First Solar shares rose after reports China considered export curbs on advanced PV tech. With FSLR’s Q1 2026 earnings due and U.S. solar manufacturing capacity expanding, investors are weighing near-term guidance against potential competitive advantages for the U.S.-based CdTe producer.

First Solar advanced perovskite licensing with Oxford PV while filing ITC complaints over TOPCon patents and issuing conservative 2026 guidance. These concrete developments tighten its U.S. manufacturing strategy, seek IP protection that could limit imports, and set near-term expectations for revenue and volume.

Recent confirmed developments — an expanded CdTe/CdSe supply deal with 5N Plus, a record U.S. module capacity run-rate, and a $1.5B unsecured credit facility — materially strengthen First Solar's operational footing and financial flexibility, supporting FSLR's position in the S&P 500.

First Solar (FSLR) shares plunged after the company issued weak 2026 sales guidance. The firm is simultaneously shifting production toward U.S. assembly—commissioning a Louisiana plant, planning a South Carolina ‘finishing’ site, and converting Southeast Asian sites to front-end cell production to capture domestic tax credits.

First Solar (FSLR) saw a recent pullback in share price even as analysts raised price targets and the U.S. Patent Office upheld key TOPCon patents. With U.S. capacity ramping and Q4/2025 results due Feb. 24, investors face a clear catalyst that could validate the company’s manufacturing and IP strength.